Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable Sustainability Profile
Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable, is a prominent player in the pharmaceutical industry, headquartered in Mexico. Established in 1997, the company has made significant strides in the development and distribution of high-quality pharmaceutical products across various therapeutic areas, including oncology, cardiology, and infectious diseases. With a strong presence in both domestic and international markets, Grupo Somar is recognised for its commitment to innovation and excellence. The company offers a diverse portfolio of prescription medications and over-the-counter products, distinguished by their efficacy and safety. Notably, Grupo Somar has achieved several milestones, including strategic partnerships and expansions that have solidified its market position as a trusted provider in the healthcare sector.
DitchCarbon Score
How does Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable's reported carbon emissions
Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable, headquartered in Mexico (MX), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, Grupo Farmacéutico Somar appears to lack formal commitments to carbon reduction initiatives or industry-standard climate strategies, which may reflect a broader trend within the pharmaceutical sector regarding emissions transparency and climate action. Without specific emissions data or targets, it is challenging to assess their environmental impact or commitment to sustainability.
How Carbon Intensive is Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable's Industry?
How Carbon Intensive is Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable's Location?
Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
